Mitochondrial Protease ClpP is a Target for the Anticancer Compounds ONC201 and Related Analogues

[Image: see text] ONC201 is a first-in-class imipridone molecule currently in clinical trials for the treatment of multiple cancers. Despite enormous clinical potential, the mechanism of action is controversial. To investigate the mechanism of ONC201 and identify compounds with improved potency, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Graves, Paul R., Aponte-Collazo, Lucas J., Fennell, Emily M. J., Graves, Adam C., Hale, Andrew E., Dicheva, Nedyalka, Herring, Laura E., Gilbert, Thomas S. K., East, Michael P., McDonald, Ian M., Lockett, Matthew R., Ashamalla, Hani, Moorman, Nathaniel J., Karanewsky, Donald S., Iwanowicz, Edwin J., Holmuhamedov, Ekhson, Graves, Lee M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2019
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528275/
https://www.ncbi.nlm.nih.gov/pubmed/31021596
http://dx.doi.org/10.1021/acschembio.9b00222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528275/
https://www.ncbi.nlm.nih.gov/pubmed/31021596
http://dx.doi.org/10.1021/acschembio.9b00222

Ejemplares similares